Adaptin Bio (APTN) Total Non-Current Liabilities (2025 - 2026)

Adaptin Bio has disclosed Total Non-Current Liabilities across 2 years of filings, most recently posting $2.1 million for Q2 2026.

• In Q2 2026, Total Non-Current Liabilities rose 228.99% year-over-year to $2.1 million; the TTM figure through Jun 2026 stood at $2.1 million (up 228.99% YoY), while the FY2025 annual figure was $1.6 million, changed N/A from the prior year.
• Total Non-Current Liabilities came in at $2.1 million for Q2 2026 at Adaptin Bio, up from $1.9 million in the prior quarter.
• In the past five years, Total Non-Current Liabilities ranged from a high of $2.1 million in Q2 2026 to a low of $557471.0 in Q1 2025.